Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
Zeynep Alkin,1 Irfan Perente,1 Abdullah Ozkaya,1 Dilek Alp,1 Alper Agca,1 Ebru Demet Aygit,1 Selcuk Korkmaz,2 Ahmet Taylan Yazici,1 Ahmet Demirok1 1Beyoglu Eye Training and Research Hospital, Istanbul, Turkey; 2Hacettepe University Faculty of Science, Department of Statistics, Ankara, Turkey Purpo...
Saved in:
Main Authors: | Alkin Z, Perente I, Ozkaya A, Alp D, Agca A, Aygit ED, Korkmaz S, Yazici AT, Demirok A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/1bd4be43b9c54b0a832b38d55ddb99d0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
by: Sanguansak T, et al.
Published: (2015) -
3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization
by: Yu-Chen Hu, et al.
Published: (2021) -
Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
by: Ratanasukon M, et al.
Published: (2013) -
Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy
by: Dhirani NA, et al.
Published: (2017) -
Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
by: Fujita K, et al.
Published: (2012)